Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer.

@article{Konecny2004Her2neuGA,
  title={Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer.},
  author={Gottfried E. Konecny and Christoph Thomssen and Hans Joachim L{\"u}ck and Michael Untch and He-jing Wang and Walter Kuhn and Holger Eidtmann and Andreas du Bois and Sigrid Olbricht and Dieter Steinfeld and Volker J Moebus and Gunter von Minckwitz and Suganda Dandekar and Lillian Ramos and Giovanni Pauletti and Mark D. Pegram and F. J{\"a}nicke and Dennis J. Slamon},
  journal={Journal of the National Cancer Institute},
  year={2004},
  volume={96 15},
  pages={1141-51}
}
BACKGROUND HER-2/neu overexpression appears to be associated with improved response to anthracycline-based chemotherapy, but its association with response to taxane-based chemotherapy is unclear. In this retrospective subset analysis of patients with metastatic breast cancer enrolled in a randomized treatment trial, we investigated the response of patients… CONTINUE READING